Document is current
Any future updates will be listed below
-
Authors
Lin, Yi-En
Yang, Shu-Mei
Huang, Chi-Jung
Tsai, Yi-Wen
Cheng, Hao-Min
Lee, Wui-Chiang
Wang, Shuu-Jiun
-
Funding
Funding for this research was provided by:
Ministry of Health and Welfare (MOHW113-IM-I-212-000013-16, MOHW114-IM-I-212-000004-5)
- License Information
-
More Information
Article History
Received: 25 November 2025
Accepted: 19 April 2026
First Online: 6 May 2026
Competing interests
: S.-J.W. reports grants/contracts from Eli Lilly Taiwan, Novartis, and Orient Europharma; consulting fees from AbbVie, Eli Lilly Taiwan, Percept Co., and Pfizer; and honoraria from AbbVie, Biogen, Eli Lilly, Hava Biopharma, and Pfizer. All other authors declare no competing financial or non-financial interests.
